🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis

Recruitingn/aAges 18 Years - anyAllProf Dr Frank Buttgereit
NCT02719314 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Glucocorticoids remain to be among the most important and most frequently used anti-inflammatory and immunosuppressive or immune-modulatory acting drugs to treat rheumatic (and other) diseases. Unfortunately, glucocorticoids also exert undesired effects, especially if higher dosages have to be given over longer periods of time. The available data describing frequency and severity of these adverse effects are fragmentary. This statement is especially true for glucocorticoid-induced osteoporosis (GIOP) in the context of chronic inflammatory rheumatic diseases or (in part) psoriasis(arthritis). The state of knowledge and scientific data, being sparse, is partly conflicting and often derived from over-aged projects or studies. Therefore, there are urgent needs to work on various current questions systematically and at the highest scientific level possible. In order to address these needs, we

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Every patient has to fulfill the following inclusion criteria: * patients with (control group: without) a diagnosis of a chronic inflammatory rheumatic disease or psoriasis * patients who (not for control groups) have/had already a glucocorticoid therapy, or patients in which the implementation of a new long-term GC therapy is expected * patients who, according to the Dachverband Osteologie (DVO, Germany) guidelines, attend our osteoporosis and bone metabolism outpatient consultation hours or are referred by the hospital wards of the Charité for diagnosis, treatment or follow-up * capability to understand the patient information * consent to participation in the project and storage of data Exclusion Criteria: If any of the following exclusion criteria is true, the patient must not be included in this study: * alcohol, medication and/or drug addiction * severe psychiatric diseases limiting the comprehension of the project plan and the study protocol (persons incapable of giving informed consent) * pregnant and lactating patients * patients incapable of giving informed consent for any reason * prisoners and all persons who are committed to an institution due to an official or judicial order
💊

What it tests

  • Glucocorticoid treatment
📍

Where

1 site
Charité University Medicine Berlin (CCM)
Berlin, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy